Page 26 - Genomic Medicine in Emerging Economies
P. 26

Sri Lanka’s Initial Experience in Implementing Genomic Medicine   15




           A special issue on genomic successes in the developing world in the Journal of
           Applied and Translational Genomics in 2016 served to demonstrate that the need,
           desire, and capacity to implement genomic medicine in developing countries
           exist and that pockets of excellence exist where resources and manpower are
           available (Dissanayake and Barash, 2016). A survey on unmet needs, con-
           ducted on participants at the Asia Pacific Society of Human Genetics Meeting
           in Hanoi in 2015, published in the same journal, provides insight into what
           is needed to achieve widespread and equitable implementation of genomic
           medicine (Isaacson Barash, 2016). The participants identified the lack of bio-
           informatics and computational tools, absence of trained data scientists, lack
           of access to datasets, and lack of funding as some of the reasons contributing
           to the disparity between the developing world and the West. Areas identified
           through the survey that need further attention include the following: (1) the
           need to convince policy makers that genomics is important and that funding
           genomics infrastructure and genomics education for health care workers is
           the crucial first step in the path to implementing genomic medicine, (2) the
           need for researchers to collaborate, (3) the need for different labs to share
           their internal data, (4) the need for global help with basic clinical research,
           (5) the need for affordable genetic and genomic tests, (6) the need to design
           laws and regulations to ensure the existence of public genomic health pro-
           grams, (7) and the need to train data scientists (Isaacson Barash,  2016).
           Some of the research and clinical delivery needs that have become barriers
           to implementing genomic medicine in developing countries are illustrated
           in Fig. 2.1.
           In view of the barriers identified above, specific measures need to be put in
           place  to  establish  viable  translational  and  precision  medicine  initiatives  in
           developing countries (Isaacson Barash, 2016). These measures are summarized
           in Fig. 2.2.


           SRI LANKA’S INITIAL EXPERIENCE IN IMPLEMENTING
           GENOMIC MEDICINE

           As a result of increased access to information through the Internet and high
           penetration of mobile technologies, news related to advances in genomics is
           rapidly reaching the shores of developing countries like Sri Lanka faster than
           ever before. In addition, expatriate communities from developing countries,
           such as Sri Lanka, who live in the affluent West often share information of
           such advances with their friends and relatives back home. In certain instances,
           the health care of relatives left behind in home countries is paid for by their
           relatives in the affluent West who demand a similar level of service in their
           home countries. We experience this frequently in Sri Lanka. Most of the time
           the local demand for genetic and genomic services that is created through such
           influences is unmet in developing countries such as ours because our medical
   21   22   23   24   25   26   27   28   29   30   31